Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
CARL · NASDAQ · Surgical & Medical Instruments & Apparatus
$17.42+0.20 (+1.16%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Carlsmed (CARL) · oqro.io/stocks/CARL · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
Insider trade · Traded Nov 3, 2026 · Filed Nov 4, 2026
Officer sold ~$11K of CARL shares in the open marketSourcePlanned sale · Planned for Nov 3, 2026 · Notice filed Nov 3, 2026
Officer filed to sell about $11K of CARL stockSourceInsider trade · Traded Oct 30, 2026 · Filed Nov 2, 2026
Officer sold ~$3.8K of CARL shares in the open marketSourcePlanned sale · Planned for Oct 30, 2026 · Notice filed Oct 30, 2026
Officer filed to sell about $3.8K of CARL stockSourcePlanned sale · Planned for Oct 14, 2026 · Notice filed Oct 14, 2026
Officer filed to sell about $58K of CARL stockSourceInsider trade · Traded Oct 5, 2026 · Filed Oct 7, 2026
Officer sold ~$11K of CARL shares in the open marketSourcePlanned sale · Planned for Oct 5, 2026 · Notice filed Oct 5, 2026
Officer filed to sell about $11K of CARL stockSourceInsider trade · Traded Sep 30, 2026 · Filed Oct 2, 2026
Officer sold ~$3.4K of CARL shares in the open marketSourceInsider trade · Traded Jul 24, 2025 · Filed Sep 16, 2026
10% owner purchased ~$3M of CARL shares in the open marketSourceInsider trade · Traded Mar 2, 2026 · Filed Mar 5, 2026
CEO sold ~$2.63M of CARL shares in the open marketSourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
Orbimed Advisors LLC disclosed a new position in CARL for Q3 2025SourceInsider trade · Traded Jul 24, 2025 · Filed Jul 25, 2025
Director purchased ~$20M of CARL shares in the open marketSourceInsider trade · Traded Jul 24, 2025 · Filed Jul 25, 2025
Director purchased ~$7M of CARL shares in the open marketSourceInsider trade · Traded Jul 24, 2025 · Filed Jul 25, 2025
10% owner purchased ~$20M of CARL shares in the open marketSourceInsider trade · Traded Jul 24, 2025 · Filed Jul 25, 2025
Director purchased ~$200K of CARL shares in the open marketSourceInsider trade · Traded Jul 24, 2025 · Filed Jul 25, 2025
Director purchased ~$100K of CARL shares in the open marketSourceInsider trade · Traded Jul 24, 2025 · Filed Jul 25, 2025
Director purchased ~$800K of CARL shares in the open marketSource